Why Lyme Tests Can Be Negative Despite Ongoing Symptoms

Many patients ask: why are my Lyme tests negative if I still have symptoms?

Patients with Lyme disease symptoms may have negative or incomplete test results. This can be confusing—especially when symptoms persist.

Clinical insight: Lyme disease is often identified by patterns of symptoms and exposure history, not by a single test result.

When Lyme Testing Does Not Match Symptoms

Standard Lyme disease testing follows a two-tier approach: an ELISA screening test followed by a Western blot if positive. This method was developed for surveillance and may miss cases—particularly early in illness or when the immune response is limited, as seen in delayed Lyme disease diagnosis.

Antibody tests are not designed to determine whether infection has resolved and may not reflect ongoing symptoms.

These tests do not evaluate for common tick-borne coinfections, which may contribute to persistent or overlapping symptoms.

In addition, early antibiotic treatment or the use of corticosteroids may influence antibody production and affect test results.

Clinical observation: Some patients may have persistent IgM antibodies without developing IgG, while others show IgG or mixed patterns that do not correlate with symptoms.

Clinical takeaway: Laboratory results are one part of the evaluation. Symptoms, exposure history, and pattern recognition remain essential.

Western Blot Bands and Their Interpretation

The Western blot detects antibodies to specific proteins of Borrelia burgdorferi, the bacterium that causes Lyme disease. Results are reported as bands, each representing a different antigen.

Bands commonly associated with Lyme disease include:

IgM: 23, 39, 41
IgG: 18, 23, 28, 30, 31, 34, 39, 41, 45, 58, 66, 93

Certain bands—particularly 31 and 34—have been associated with Borrelia but are not included in standard surveillance criteria.

Surveillance criteria were established for consistency in public health reporting and may not capture all clinically relevant cases, especially in early or evolving illness.

In clinical practice, some laboratories use broader interpretive approaches, suggesting that fewer bands may still be meaningful when consistent with symptoms and exposure history.

Clinical context matters: No single band or test result should be interpreted in isolation.

Why Clinical Diagnosis Still Matters

Lyme disease may be diagnosed clinically when symptoms, exposure risk, and supporting findings suggest infection—even when testing is negative or incomplete.

This reflects variability in immune response and the limitations of Lyme disease testing.

Key point: Laboratory testing supports diagnosis, but does not replace clinical judgment.

Advances in Lyme Disease Testing

Diagnostic testing for Lyme disease continues to evolve, with ongoing efforts to improve sensitivity and earlier detection. While newer approaches show promise, current testing may still not capture all cases—particularly in early or clinically complex presentations.

Newer approaches include enhanced antibody testing, direct detection methods such as PCR, and emerging technologies designed to identify infection earlier. Each approach offers potential advantages but also has limitations and is still being evaluated.

Final perspective: Understanding the limitations of testing—and the meaning of specific Western blot bands—can help explain why Lyme tests may be negative despite ongoing symptoms.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention